"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties"
"CHEMBL345237";"PICLOZOTAN";"2";"409.92";"0";"4.52";"5";"O=C1c2ccccc2OC=C(Cl)N1CCCCN1CC=C(c2ccccn2)CC1";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"17.26";"0.33";"2.56";"15.49";"False";"CHEMBL667500";"Binding affinity to Dopamine receptor D2 in of rat striatum membrane with [3H]- raclopride as radioligand";"B";"BAO_0000249";"cell membrane format";"None";"CHEMBL3638255";"Striatum";"None";"None";"";"";"";"CHEMBL339";"Dopamine D2 receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1134206";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859771";"Binding affinity to bovine 5HT1D receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Bos taurus";"None";"None";"None";"None";"";"";"";"CHEMBL1983";"Serotonin 1d (5-HT1d) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859021";"Binding affinity to human 5HT5A receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3426";"Serotonin 5a (5-HT5a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Inhibition";"";"";"%";"";"";"Not Active";"";"";"";"";"";"False";"CHEMBL859027";"Inhibition of human recombinant cytochrome P450 2C19";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3622";"Cytochrome P450 2C19";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Inhibition";"";"";"%";"";"";"Not Active";"";"";"";"";"";"False";"CHEMBL859028";"Inhibition of human recombinant cytochrome P450 2D6";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL289";"Cytochrome P450 2D6";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Cmax";"'='";"0.174";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"False";"CHEMBL859034";"Cmax in Beagle dog at 3 mg/kg, po";"A";"BAO_0000218";"organism-based format";"Canis lupus familiaris";"None";"None";"None";"None";"DOSE = 3.0 mg.kg-1 | ROUTE: Oral";"";"";"CHEMBL373";"Canis familiaris";"Canis lupus familiaris";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"BBR";"'='";"0.5";"";"";"";"";"";"";"";"";"";"False";"CHEMBL859035";"Ratio of drug level in brain against serum in Sprague-Dawley rat at 3 mg/kg, po or 1 mg/kg, iv after 1 hr";"A";"BAO_0000218";"organism-based format";"Rattus norvegicus";"CHEMBL3987521";"Brain/Serum";"None";"None";"";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859037";"Binding affinity to adrenergic alpha receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859047";"Binding affinity to cholecystokinin receptor by radioligand binding assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2095185";"Cholecystokinin receptor";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859048";"Binding affinity to chemokine receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862266";"Binding affinity to neuropeptide receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL1742408";"OSEMOZOTAN";"3";"343.38";"0";"2.61";"osemozotan";"c1ccc2c(c1)OC[C@H](CNCCCOc1ccc3c(c1)OCO3)O2";"Inhibition";"'='";"0.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL4513082";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4495565";"52";"SARS-CoV-2 Screening Data 2020-21";"";"2020";"CHEMBL4295411";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"T1/2";"'>'";"10.0";"hr";"";"";"";"UO_0000032";"";"";"";"";"False";"CHEMBL861671";"Terminal half life in human";"A";"BAO_0000218";"organism-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL372";"Homo sapiens";"Homo sapiens";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL1628569";"ROBALZOTAN";"2";"318.39";"0";"2.64";"robalzotan";"NC(=O)c1ccc(F)c2c1C[C@@H](N(C1CCC1)C1CCC1)CO2";"Inhibition";"'='";"-0.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL4513082";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4495565";"52";"SARS-CoV-2 Screening Data 2020-21";"";"2020";"CHEMBL4295411";""
"CHEMBL345237";"PICLOZOTAN";"2";"409.92";"0";"4.52";"5";"O=C1c2ccccc2OC=C(Cl)N1CCCCN1CC=C(c2ccccn2)CC1";"IC50";"'='";"0.47";"nM";"9.33";"";"";"UO_0000065";"22.76";"0.44";"4.81";"20.42";"False";"CHEMBL615830";"Binding affinity to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand";"B";"BAO_0000221";"tissue-based format";"None";"CHEMBL3638273";"Hippocampus";"None";"None";"";"";"";"CHEMBL273";"Serotonin 1a (5-HT1a) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1134206";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"None";""
"CHEMBL220808";"SARIZOTAN";"3";"348.42";"0";"4.37";"2";"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1";"Ki";"'='";"19.05";"nM";"7.72";"";"";"UO_0000065";"22.16";"0.41";"3.35";"22.61";"False";"CHEMBL907460";"Displacement of [3H]YM-09151-2 from rat striatum D2 receptor";"B";"BAO_0000357";"single protein format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL339";"Dopamine D2 receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1141420";"1";"Scientific Literature";"J. Med. Chem.";"2007";"None";""
"CHEMBL345237";"PICLOZOTAN";"2";"409.92";"0";"4.52";"5";"O=C1c2ccccc2OC=C(Cl)N1CCCCN1CC=C(c2ccccn2)CC1";"Ratio";"'='";"179.0";"";"";"";"";"";"";"";"";"";"False";"CHEMBL616324";"Ratio of binding affinity to 5-HT 1A and D2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL273";"Serotonin 1a (5-HT1a) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1134206";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"ED50";"'>'";"40.0";"mg.kg-1";"";"";"";"UO_0000308";"";"";"";"";"False";"CHEMBL895217";"Induction of flat body posture in orally dosed rat as after 60 mins";"F";"BAO_0000218";"organism-based format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1148798";"1";"Scientific Literature";"J. Med. Chem.";"2007";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859043";"Binding affinity to bradykinin receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862269";"Binding affinity to chloride channel by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612546";"Molecular identity unknown";"";"UNKNOWN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"False";"CHEMBL862273";"Decrease in stress-induced hyperthermia in 129S6/SvEvTac mouse at 20 mg/kg, po";"F";"BAO_0000218";"organism-based format";"Mus musculus";"None";"None";"None";"None";"DOSE = 20.0 mg.kg-1 | ROUTE: Oral";"";"";"CHEMBL375";"Mus musculus";"Mus musculus";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL1742470";"EBALZOTAN";"0";"318.46";"0";"3.25";"8j";"CCCN(C(C)C)[C@H]1COc2cccc(C(=O)NC(C)C)c2C1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL617913";"In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat cortex";"B";"BAO_0000019";"assay format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL322";"Serotonin 2a (5-HT2a) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1133455";"1";"Scientific Literature";"J. Med. Chem.";"2000";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"ED50";"'>'";"40.0";"mg.kg-1";"";"";"";"UO_0000308";"";"";"";"";"False";"CHEMBL895219";"Antidepressant like activity in orally dosed rat after 60 mins by forced swimming test";"F";"BAO_0000218";"organism-based format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1148798";"1";"Scientific Literature";"J. Med. Chem.";"2007";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Activity";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL853265";"Displacement of [3H]RX 821002 from Adrenergic alpha-2a receptor in rat cerebral cortex cells at 1 uM";"B";"BAO_0000219";"cell-based format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"None";"";"";"";"CHEMBL327";"Alpha-2a adrenergic receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Inhibition";"'='";"21.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL853272";"Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay at 1 uM";"T";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL240";"HERG";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"CHEMBL3307715";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL870200";"Binding affinity to D2 receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL217";"Dopamine D2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"PPB";"'='";"92.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL859024";"Protein binding in human serum at 2 uM";"A";"BAO_0000218";"organism-based format";"Homo sapiens";"CHEMBL3638229";"Serum";"None";"None";"";"";"";"CHEMBL372";"Homo sapiens";"Homo sapiens";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"PPB";"'='";"92.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL859036";"Protein binding in human serum at 10 uM";"A";"BAO_0000218";"organism-based format";"Homo sapiens";"CHEMBL3638229";"Serum";"None";"None";"";"";"";"CHEMBL372";"Homo sapiens";"Homo sapiens";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859045";"Binding affinity to GABA receptor by radioligand binding assay";"B";"BAO_0000223";"protein complex format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2093872";"GABA-A receptor; anion channel";"Homo sapiens";"PROTEIN COMPLEX GROUP";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862152";"Binding affinity to neurokinin receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862261";"Binding affinity to opioid receptor by radioligand binding assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2095181";"Opioid receptors; mu/kappa/delta";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"LD10";"";"";"";"";"";"Not Determined";"";"";"";"";"";"False";"CHEMBL871200";"Toxicity in po dosed Sprague-Dawley rat";"T";"BAO_0000218";"organism-based format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862265";"Binding affinity to vasopressin receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862268";"Binding affinity to potassium channel by radioligand binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL240";"HERG";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"MTD";"'='";"300.0";"mg kg-1";"";"";"";"UO_0000308";"";"";"";"";"False";"CHEMBL871200";"Toxicity in po dosed Sprague-Dawley rat";"T";"BAO_0000218";"organism-based format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"MTD";"'='";"600.0";"mg kg-1";"";"";"";"UO_0000308";"";"";"";"";"False";"CHEMBL871201";"Toxicity in po dosed Beagle dog";"T";"BAO_0000218";"organism-based format";"Canis lupus familiaris";"None";"None";"None";"None";"";"";"";"CHEMBL373";"Canis familiaris";"Canis lupus familiaris";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Activity";"'='";"47.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL870207";"Displacement of [3H]prazosin from Adrenergic alpha-1 receptor in rat cerebral cortex cells at 1 uM";"B";"BAO_0000219";"cell-based format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"None";"";"";"";"CHEMBL1907610";"Adrenergic receptor alpha-1";"Rattus norvegicus";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"17.24";"0.34";"4.72";"9.50";"False";"CHEMBL859016";"Binding affinity to 5HT1A receptor in rat cerebral cortex by radioligand binding assay";"B";"BAO_0000221";"tissue-based format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"None";"";"";"";"CHEMBL273";"Serotonin 1a (5-HT1a) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL853267";"Binding affinity to 5HT2A receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL224";"Serotonin 2a (5-HT2a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Inhibition";"";"";"%";"";"";"Not Active";"";"";"";"";"";"False";"CHEMBL859026";"Inhibition of human recombinant cytochrome P450 2C9";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3397";"Cytochrome P450 2C9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859038";"Binding affinity to beta adrenergic receptor by radioligand binding assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2094118";"Adrenergic receptor beta";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859041";"Binding affinity to angiotensin2 receptor by radioligand binding assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2094256";"Angiotensin II receptor";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862262";"Binding affinity to somatostatin receptor by radioligand binding assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2111436";"Somatostatin receptor";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"18.40";"0.37";"5.24";"10.14";"False";"CHEMBL870197";"Displacement of [3H]8-OH-DPAT from human 5HT1A receptor in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"CHEMBL3307715";""
"CHEMBL1742470";"EBALZOTAN";"0";"318.46";"0";"3.25";"8j";"CCCN(C(C)C)[C@H]1COc2cccc(C(=O)NC(C)C)c2C1";"Efficacy";"'='";"74.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL615815";"Percent inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation in GH4ZD10 cells expressing 5-HT1A receptor at 50 uM relative to 5-HT";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"GH4ZD10";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133455";"1";"Scientific Literature";"J. Med. Chem.";"2000";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"False";"CHEMBL862274";"Decrease in basal rectal temperature in stress-induced hyperthermic 129S6/SvEvTac mouse at 20 mg/kg, po";"F";"BAO_0000218";"organism-based format";"Mus musculus";"None";"None";"None";"None";"DOSE = 20.0 mg.kg-1 | ROUTE: Oral";"";"";"CHEMBL375";"Mus musculus";"Mus musculus";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Emax";"'='";"6.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL895215";"Agonist activity at human 5HT1A receptor expressed in C6 cells assessed as stimulation of [35S]GTP-gamma-S binding relative to 5-hydroxytryptamine";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"C6";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148798";"1";"Scientific Literature";"J. Med. Chem.";"2007";"CHEMBL3308345";""
"CHEMBL220808";"SARIZOTAN";"3";"348.42";"0";"4.37";"2";"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1";"Emax";"'='";"66.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL907462";"Agonist activity at human 5HT1A receptor in HeLa cells assessed as stimulation of [35S]GTPgammaS binding relative to serotonin";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141420";"1";"Scientific Literature";"J. Med. Chem.";"2007";"CHEMBL3308376";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862264";"Binding affinity to vasoactive intestinal peptide receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"11c";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"Emax";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL837519";"Agonist activity in forskolin-induced cAMP production in CHO cells expressing 5-HT1A receptor compared to 8-OH-DPAT";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139501";"1";"Scientific Literature";"J. Med. Chem.";"2005";"CHEMBL3308072";""
"CHEMBL1742470";"EBALZOTAN";"0";"318.46";"0";"3.25";"8j";"CCCN(C(C)C)[C@H]1COc2cccc(C(=O)NC(C)C)c2C1";"Ki";"'='";"7.77";"nM";"8.11";"";"";"UO_0000065";"25.46";"0.48";"4.86";"19.51";"False";"CHEMBL615972";"In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes";"B";"BAO_0000249";"cell membrane format";"None";"CHEMBL3638273";"Hippocampus";"None";"Membrane";"";"";"";"CHEMBL273";"Serotonin 1a (5-HT1a) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1133455";"1";"Scientific Literature";"J. Med. Chem.";"2000";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.53";"0.31";"3.95";"8.56";"False";"CHEMBL862272";"Binding affinity to guinea pig sigma receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Cavia porcellus";"None";"None";"None";"None";"";"";"";"CHEMBL287";"Sigma opioid receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"False";"CHEMBL863007";"Transient increase in prolactin level in human serum at greater than 30 mg";"F";"BAO_0000218";"organism-based format";"Homo sapiens";"CHEMBL3638229";"Serum";"None";"None";"";"";"";"CHEMBL372";"Homo sapiens";"Homo sapiens";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"F";"'='";"16.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL859033";"Oral bioavailability in Beagle dog at 3 mg/kg, po and 1 mg/kg, iv";"A";"BAO_0000218";"organism-based format";"Canis lupus familiaris";"None";"None";"None";"None";"";"";"";"CHEMBL373";"Canis familiaris";"Canis lupus familiaris";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859042";"Binding affinity to benzodiazepine receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5742";"Translocator protein";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Inhibition";"";"";"%";"";"";"Not Active";"";"";"";"";"";"False";"CHEMBL859025";"Inhibition of human recombinant cytochrome P450 1A2";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3356";"Cytochrome P450 1A2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL220808";"SARIZOTAN";"3";"348.42";"0";"4.37";"58";"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1";"IC50";"'<'";"6.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL945906";"Binding affinity to human dopaminergic D3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL234";"Dopamine D3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141467";"1";"Scientific Literature";"J. Med. Chem.";"2008";"None";""
"CHEMBL220808";"SARIZOTAN";"3";"348.42";"0";"4.37";"58";"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1";"IC50";"'<'";"6.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL945907";"Binding affinity to human dopaminergic D4 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL219";"Dopamine D4 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141467";"1";"Scientific Literature";"J. Med. Chem.";"2008";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859017";"Binding affinity to 5HT1B receptor in rat cerebral cortex by radioligand binding assay";"B";"BAO_0000221";"tissue-based format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"None";"";"";"";"CHEMBL3459";"Serotonin 1b (5-HT1b) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL853268";"Binding affinity to 5HT2B receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1833";"Serotonin 2b (5-HT2b) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859020";"Binding affinity to human 5HT4e receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1875";"Serotonin 4 (5-HT4) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"EC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL870204";"Activity against 5HT1A receptor by Gi-[35S]GTP-gamma-S binding assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"F";"'='";"11.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL870206";"Oral bioavailability in Sprague-Dawley rat at 3 mg/kg, po and 1 mg/kg, iv";"A";"BAO_0000218";"organism-based format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859044";"Binding affinity to endothelin receptor by radioligand binding assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2096678";"Endothelin receptor, ET-A/ET-B";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859046";"Binding affinity to galanin receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL866980";"Binding affinity to melanocortin receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"ED50";"'>'";"40.0";"mg.kg-1";"";"";"";"UO_0000308";"";"";"";"";"False";"CHEMBL895216";"Induction of forepaw treading in orally dosed rat after 60 mins";"F";"BAO_0000218";"organism-based format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1148798";"1";"Scientific Literature";"J. Med. Chem.";"2007";"None";""
"CHEMBL220808";"SARIZOTAN";"3";"348.42";"0";"4.37";"58";"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1";"IC50";"'<'";"6.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL945908";"Binding affinity to human 5HT1A receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141467";"1";"Scientific Literature";"J. Med. Chem.";"2008";"None";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"11c";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL831439";"In vitro inhibition of 8-OH-DPAT-induced [35S]GTP-gamma-S, binding to 5-HT1A receptor/G protein complex in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139501";"1";"Scientific Literature";"J. Med. Chem.";"2005";"CHEMBL3308072";""
"CHEMBL1742470";"EBALZOTAN";"0";"318.46";"0";"3.25";"8j";"CCCN(C(C)C)[C@H]1COc2cccc(C(=O)NC(C)C)c2C1";"Ki";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL670882";"In vitro binding affinity at human cloned Dopamine receptor D2A measured by ability to displace [3H]raclopride from D2A receptor expressed in mouse fibroblast (LtK-) cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL217";"Dopamine D2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133455";"1";"Scientific Literature";"J. Med. Chem.";"2000";"None";""
"CHEMBL1742470";"EBALZOTAN";"0";"318.46";"0";"3.25";"8j";"CCCN(C(C)C)[C@H]1COc2cccc(C(=O)NC(C)C)c2C1";"Ki";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL670444";"In vitro binding affinity at D1 receptor by measuring its ability to displace [3H]SCH-23390 from Dopamine receptor D1 in rat striatum";"B";"BAO_0000019";"assay format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL265";"Dopamine D1 receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1133455";"1";"Scientific Literature";"J. Med. Chem.";"2000";"None";""
"CHEMBL220808";"SARIZOTAN";"3";"348.42";"0";"4.37";"2";"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1";"EC50";"'='";"77.62";"nM";"7.11";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL907461";"Agonist activity at human 5HT1A receptor in HeLa cells assessed as stimulation of [35S]GTP-gamma-S binding";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141420";"1";"Scientific Literature";"J. Med. Chem.";"2007";"CHEMBL3308376";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"11c";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL827482";"In vitro antagonism of 8-OH-DPAT inhibition of forskolin-induced cAMP production in CHO cells expressing 5-HT1A receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139501";"1";"Scientific Literature";"J. Med. Chem.";"2005";"CHEMBL3308072";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"16";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"12.03";"0.24";"2.37";"6.63";"False";"CHEMBL1027667";"Inhibition of human ERG channel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL240";"HERG";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137783";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'='";"30.2";"nM";"7.52";"";"";"UO_0000065";"16.69";"0.33";"4.47";"9.20";"False";"CHEMBL895213";"Binding affinity to 5HT1A receptor in rat cortex membrane";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3638219";"Cortex";"None";"None";"";"";"";"CHEMBL273";"Serotonin 1a (5-HT1a) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1148798";"1";"Scientific Literature";"J. Med. Chem.";"2007";"None";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"11c";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"Ki";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"18.19";"0.33";"5.22";"10.74";"False";"CHEMBL830432";"Displacement of 8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in chinese hamster ovary cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139501";"1";"Scientific Literature";"J. Med. Chem.";"2005";"CHEMBL3308072";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"11c";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"Emax";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL831047";"Percent maximal response of 8-OH-DPAT-induced [35S]GTP-gamma-S, binding to 5-HT1A receptor/G protein complex ";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139501";"1";"Scientific Literature";"J. Med. Chem.";"2005";"None";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"11c";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"ED50";"'='";"3.68";"mg.kg-1";"";"";"";"UO_0000308";"";"";"";"";"False";"CHEMBL834582";"Effective dose on the 8-OH-DPAT induced response at 3 mg/kg sc in presence of 8-OH-DPAT (Effective dose value for 8-OH-DPAT = 0.18)";"F";"BAO_0000218";"organism-based format";"Rattus norvegicus";"None";"None";"None";"None";"DOSE = 3.0 mg.kg-1 | ROUTE: Subcutaneous";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1139501";"1";"Scientific Literature";"J. Med. Chem.";"2005";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862267";"Binding affinity to sodium channel by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862271";"Binding affinity to dopamine transporter by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL238";"Dopamine transporter";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"T1/2";"'='";"0.4667";"hr";"";"";"";"UO_0000032";"";"";"";"";"False";"CHEMBL853271";"Half life in human liver microsome at 5 uM";"A";"BAO_0000251";"microsome format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsome";"";"";"";"CHEMBL613373";"Liver microsomes";"Homo sapiens";"SUBCELLULAR";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL220808";"SARIZOTAN";"3";"348.42";"0";"4.37";"58";"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1";"IC50";"'<'";"6.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL945897";"Binding affinity to 5HT3 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1899";"Serotonin 3a (5-HT3a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141467";"1";"Scientific Literature";"J. Med. Chem.";"2008";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"12.86";"0.26";"2.75";"7.09";"False";"CHEMBL870198";"Displacement of [3H]prazosin from adrenergic alpha-1 receptor in rat cerebral cortex cells";"B";"BAO_0000219";"cell-based format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"None";"";"";"";"CHEMBL1907610";"Adrenergic receptor alpha-1";"Rattus norvegicus";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862153";"Binding affinity to neurotensin receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL866981";"Binding affinity to muscarinic receptor by radioligand binding assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2094109";"Muscarinic acetylcholine receptor";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862260";"Binding affinity to orphanin receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2014";"Nociceptin receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862270";"Binding affinity to norepinephrine transporter by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL222";"Norepinephrine transporter";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"";"";"";"";"True";"CHEMBL853270";"Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay";"T";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL240";"HERG";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"CHEMBL3307715";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859022";"Binding affinity to human 5HT6 receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3371";"Serotonin 6 (5-HT6) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL345237";"PICLOZOTAN";"2";"409.92";"0";"4.52";"5";"O=C1c2ccccc2OC=C(Cl)N1CCCCN1CC=C(c2ccccn2)CC1";"Inhibition";"'<'";"63.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL799217";"Neuronal protective effect of compound against ischemic brain damage in rat t-MCAO model";"F";"BAO_0000218";"organism-based format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1134206";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859018";"Binding affinity to human 5HT2C receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL225";"Serotonin 2c (5-HT2c) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"T1/2";"'='";"1.1";"hr";"";"";"";"UO_0000032";"";"";"";"";"False";"CHEMBL859032";"Half life in Beagle dog at 3 mg/kg, po";"A";"BAO_0000218";"organism-based format";"Canis lupus familiaris";"None";"None";"None";"None";"DOSE = 3.0 mg.kg-1 | ROUTE: Oral";"";"";"CHEMBL373";"Canis familiaris";"Canis lupus familiaris";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859040";"Binding affinity to histamine receptor by radioligand binding assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Cmax";"'='";"0.024";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"False";"CHEMBL859031";"Cmax in Sprague-Dawley rat at 3 mg/kg, po";"A";"BAO_0000218";"organism-based format";"Rattus norvegicus";"None";"None";"None";"None";"DOSE = 3.0 mg.kg-1 | ROUTE: Oral";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859039";"Binding affinity to dopamine receptor by radioligand binding assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2096905";"Dopamine receptor";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"20m";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL862263";"Binding affinity to sigma receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL287";"Sigma opioid receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL1742408";"OSEMOZOTAN";"3";"343.38";"0";"2.61";"osemozotan";"c1ccc2c(c1)OC[C@H](CNCCCOc1ccc3c(c1)OCO3)O2";"Inhibition";"'='";"0.06";"%";"";"";"";"";"";"";"";"";"False";"CHEMBL4513082";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4495565";"52";"SARS-CoV-2 Screening Data 2020-21";"";"2020";"CHEMBL4295411";""
"CHEMBL220808";"SARIZOTAN";"3";"348.42";"0";"4.37";"58";"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1";"IC50";"'<'";"6.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL945905";"Binding affinity to human dopaminergic D2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL217";"Dopamine D2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141467";"1";"Scientific Literature";"J. Med. Chem.";"2008";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"EC50";"'='";"93.33";"nM";"7.03";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL895214";"Agonist activity at human 5HT1A receptor expressed in C6 cells assessed as stimulation of [35S]GTPgammaS binding";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"C6";"None";"";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148798";"1";"Scientific Literature";"J. Med. Chem.";"2007";"CHEMBL3308345";""
"CHEMBL220808";"SARIZOTAN";"3";"348.42";"0";"4.37";"2";"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1";"Ki";"'='";"2.239";"nM";"8.65";"";"";"UO_0000065";"24.83";"0.45";"4.28";"25.33";"False";"CHEMBL907458";"Displacement of [3H]OH-DPAT from rat cortex 5HT1A receptor";"B";"BAO_0000019";"assay format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL273";"Serotonin 1a (5-HT1a) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1141420";"1";"Scientific Literature";"J. Med. Chem.";"2007";"None";""
"CHEMBL220808";"SARIZOTAN";"3";"348.42";"0";"4.37";"2";"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1";"Ki";"'='";"2137.96";"nM";"5.67";"";"";"UO_0000065";"16.27";"0.30";"1.30";"16.60";"False";"CHEMBL907459";"Displacement of [3H]ketanserin from rat cortex 5HT2A receptor";"B";"BAO_0000019";"assay format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL322";"Serotonin 2a (5-HT2a) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1141420";"1";"Scientific Literature";"J. Med. Chem.";"2007";"None";""
"CHEMBL1742408";"OSEMOZOTAN";"3";"343.38";"0";"2.61";"osemozotan";"c1ccc2c(c1)OC[C@H](CNCCCOc1ccc3c(c1)OCO3)O2";"Inhibition";"'='";"7.988";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL4495582";"SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate";"F";"BAO_0000019";"assay format";"Severe acute respiratory syndrome coronavirus 2";"None";"None";"None";"None";"";"";"";"CHEMBL4523582";"Replicase polyprotein 1ab";"Severe acute respiratory syndrome coronavirus 2";"SINGLE PROTEIN";"CHEMBL4495564";"52";"SARS-CoV-2 Screening Data 2020-21";"";"2020";"None";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"Lecozotan";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"IC50";"'<'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4017550";"Inhibition of human BSEP expressed in baculovirus transfected fall armyworm Sf21 cell membranes vesicles assessed as reduction in ATP-dependent [3H]-taurocholate transport into vesicles incubated for 5 mins by Topcount based rapid filtration method";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6020";"Bile salt export pump";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017441";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"4330";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";"None";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"4330";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";"None";""
"CHEMBL1628569";"ROBALZOTAN";"2";"318.39";"0";"2.64";"ROBALZOTAN";"NC(=O)c1ccc(F)c2c1C[C@@H](N(C1CCC1)C1CCC1)CO2";"Inhibition";"'='";"24.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL4303805";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging";"F";"BAO_0000218";"organism-based format";"Homo sapiens";"None";"None";"Caco-2";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4303101";"52";"SARS-CoV-2 Screening Data 2020-21";"";"2020";"CHEMBL3307519";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"4330";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";"None";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"4330";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";"None";""
"CHEMBL1628569";"ROBALZOTAN";"2";"318.39";"0";"2.64";"robalzotan";"NC(=O)c1ccc(F)c2c1C[C@@H](N(C1CCC1)C1CCC1)CO2";"Inhibition";"'='";"12.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL4495582";"SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate";"F";"BAO_0000019";"assay format";"Severe acute respiratory syndrome coronavirus 2";"None";"None";"None";"None";"";"";"";"CHEMBL4523582";"Replicase polyprotein 1ab";"Severe acute respiratory syndrome coronavirus 2";"SINGLE PROTEIN";"CHEMBL4495564";"52";"SARS-CoV-2 Screening Data 2020-21";"";"2020";"None";""
"CHEMBL1742408";"OSEMOZOTAN";"3";"343.38";"0";"2.61";"OSEMOZOTAN";"c1ccc2c(c1)OC[C@H](CNCCCOc1ccc3c(c1)OCO3)O2";"Inhibition";"'='";"-8.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL4303805";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging";"F";"BAO_0000218";"organism-based format";"Homo sapiens";"None";"None";"Caco-2";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4303101";"52";"SARS-CoV-2 Screening Data 2020-21";"";"2020";"CHEMBL3307519";""
"CHEMBL1628569";"ROBALZOTAN";"2";"318.39";"0";"2.64";"robalzotan";"NC(=O)c1ccc(F)c2c1C[C@@H](N(C1CCC1)C1CCC1)CO2";"Inhibition";"'='";"-0.22";"%";"";"";"";"";"";"";"";"";"False";"CHEMBL4513082";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4495565";"52";"SARS-CoV-2 Screening Data 2020-21";"";"2020";"CHEMBL4295411";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL859019";"Binding affinity to mouse 5HT3 receptor by radioligand binding assay";"B";"BAO_0000224";"protein format";"Mus musculus";"None";"None";"None";"None";"";"";"";"CHEMBL2111333";"Serotonin 3 receptor (5HT3)";"Mus musculus";"PROTEIN FAMILY";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Ki";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"13.66";"0.27";"3.10";"7.53";"False";"CHEMBL853266";"Binding affinity to 5HT7 receptor by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3155";"Serotonin 7 (5-HT7) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"T1/2";"'='";"1.083";"hr";"";"";"";"UO_0000032";"";"";"";"";"False";"CHEMBL859023";"Half life in human liver S9 fraction at 5 uM";"A";"BAO_0000218";"organism-based format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"S9 fraction";"";"";"";"CHEMBL372";"Homo sapiens";"Homo sapiens";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"Inhibition";"";"";"%";"";"";"Not Active";"";"";"";"";"";"False";"CHEMBL859029";"Inhibition of human recombinant cytochrome P450 3A4";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL340";"Cytochrome P450 3A4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL209821";"NALUZOTAN";"3";"450.65";"0";"3.05";"PRX-00023";"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1";"T1/2";"'='";"2.0";"hr";"";"";"";"UO_0000032";"";"";"";"";"False";"CHEMBL870205";"Half life in Sprague-Dawley rat at 3 mg/kg, po";"A";"BAO_0000218";"organism-based format";"Rattus norvegicus";"None";"None";"None";"None";"DOSE = 3.0 mg.kg-1 | ROUTE: Oral";"";"";"CHEMBL376";"Rattus norvegicus";"Rattus norvegicus";"ORGANISM";"CHEMBL1147799";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
